[CIS-PAGID] Tough case
Wilmer Cordova Calderon
wilmer.cordova at gmail.com
Fri Mar 23 20:36:15 EDT 2012
•IF not reached a definitive diagnosis
•WHAT TREATMENT IMMUNE SUPPORT WE WILL NEED OPTIMIZATION?
2012/3/23 Pere Soler Palacin <psoler at vhebron.net>
>
> Dear colleagues, we'd really appreciate your thoughts about this tough
> case we are currently facing since we are in an impasse and the patient is
> severely ill.
>
>
>
> Fifteen month-old boy, with severe skin involvement, spleen and liver
> enlargement and hemolytic anemia that presents recurrent episodes
> compatible with macrophage activation syndrome.
>
> Clinical manifestations began at the age of 9 months with haemolytic
> anemia (positive direct Coombs test) and splenomegaly. Immunoglobulin
> plasma levels were increase. (Ig G above 1000 mg/dL and both IgA and IgM
> above 200 mg/dl) and lymphocyte subsets analysis yielded mild lymphopenia
> (1280 /mm3. Lymphocyte subpopulations at the onset of the manifestations,
> CD3+: 35% (448 /mm3), CD4+:22% (281.6 /mm3); CD8+: CD8+: 13%, (140.8 /mm3),
> CD19+: 537.6 /mm3, CD156+16+: 294.4 /mm3.
>
>
>
> Corticosteroid therapy and high dose IVIG were started ant that point, and
> since anemia was refractory to these treatments, the patient was put on
> rituximab (5 doses). The patient needed repeated (not irradiated) blood
> transfusions.
>
> At 11 months of age and because of the persistence of anemia, he was
> switched to cyclosporine and mycophenolate mofetil afterwards since ALPS
> was suspected (although DNT cells biological markers were absent). Few days
> later fever, pancytopenia and severe rash occurred and MMF was changed to
> sirolimus without significant clinical improvement. Bone marrow aspirate
> was performed and informed to be normal.
>
> The patient was sent to our centre at that point (14 mo). Physical
> examination showed hepatosplenomegaly, generalized lymphadenopathy, severe
> erytroderma with scaly skin that sheds off and pruritus (see figure).
>
> At that moment, we considered five diagnostic options:
>
> - *Histiocytosis*: skin biopsy ruled it out.
>
> - *Cutaneous T-cell lymphoma (Sezary):* skin biopsy ruled it out
> and it’s only seen in adult patients.
>
> - *ALPS/DALD:* Neither DNT cell nor biomarkers were found. No
> mutations in *TNFRSF6* (FAS) or *KRAS* genes. No DNT in lymph node biopsy.
>
> - *Hemophagocytic** lymphohistiocytosis (HLH):* initial NK cells
> cytotixicity and degranulation assays were abnormal and the patient
> presented elevated ferritin (90.000 ng/mL), tryglicerides (400 mg/dl)
> levels and hypofibrinogenemia. CD25s was 1700. BM aspirate and lymph node
> biopsy showed some signs of hemophagocytosis. Nevertheless, when
> immunosuppressant drugs were tapered enough, NK cyto and degranulation
> assays return to normal. Perforin expression was normal in CD8 and NK
> cells. Skin was not compatible with HLH.
>
> * - Leaky-SCID with Omenn or GVHD (maternal or
> post-transfusional):*
>
> - Lymphocyte subpopulations, data from our center at age 11
> months: CD3: 96% (3.973X109/L), CD4: 80% (3.296X109/L), CD8: 16% (0.668X10
> 9/L), 0% B cells (CD19+), 1% NK cells CD56+16+)
>
> - T cell population mostly activated expressing HLA-DR CD4: 58%
> and CD8: 87%.
>
> - 90% of CD3 T cells with effector memory pheenotype
> (CD45RO+CCR7-)
>
> - TCR ab/gd phenotype was evaluated 93.3%/5.3%.
>
> - CD3 and CD2 expression did not show significant differences
>
> - Absence of B cells (secondary to RTX infusion).
>
> - NK cells 1.6% (0.066X109/L),
>
> - Proliferation to PHA, PHA+IL2, IL2 and anti-CD3+IL2 was
> normal, PMA+ionomic slightly decreased and anti-CD3 response severely
> depressed.
>
>
>
> - Hypogammaglobulinemia was thought to be secondary to RTX too.
> Proliferation assays were significantly low and TCR was oligoclonally
> expressed. Chimerism assays did not show maternal or transfusional cells
> and skin biopsy was not compatible with OS. Only port-a-cath infection due
> to *P. aeruginosa* and diarrhoea due to Norovirus were demonstrated as
> significant infections. Visceral leishmaniasis has been ruled out.
>
>
>
> We tried to tapper all immunosuppressant drugs to better evaluate his
> “own” immunological status. The patient remained hematologically stable
> (only needing weekly IVIG to maintain normal Hb levels) but skin
> progressively worsened to severe and became the main clinical problem in
> our patient.
>
> Skin biopsy showed a psoriatic dermatitis and hair was normal when
> observed at optic microscope.
>
> The patient has presented two new episodes of fever, increase of spleen
> and liver size, cytopenias and skin involvement and we decided to start
> HLH-2004 protocol (VP-16 not yet) and the patient only improved
> transiently.
>
>
>
> Since, psoriatic dermatitis is described to be associated to IPEX and
> IPEX-like syndrome we analyzed FOXP3 and CD25 and were found to be normal.
> Inborn metabolic disorders) have been properly ruled out.
>
>
>
> Thanks in advance,
>
>
>
> Pere.
> Pere Soler Palacín, MD, PhD. Pediatric Infectious Diseases and
> Immunodeficiencies Unit. Hospital Universitari Vall d'Hebron. Assistant
> Professor. Universitat Autònoma
> de Barcelona.
> Passeig de la Vall d'Hebron 119-129.
> 08035 Barcelona. Spain.
> Tel: 0034934893140. Fax: 0034934893039.
> E-mail: psoler at vhebron.net; 34660psp at comb.cat. Web: www.upiip.com.
>
>
> No imprimir aquest correu ajudarà a preservar el medi ambient.
> Si vostè no és el destinatari del missatge, o l'ha rebut per error, si us
> plau notifiqui-ho al remitent i destrueixi el missatge amb tot el seu
> contingut. Està prohibida la distribució no autoritzada del contingut
> d'aquest missatge.
>
> No imprimir este correo ayudará a preservar el medio ambiente.
> Si usted no es el destinatario del mensaje, o lo ha recibido por error,
> notifíquelo por favor al remitente y destruya el mensaje con todo su
> contenido. Está prohibida la distribución no autorizada del contenido de
> este mensaje.
>
>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/mailman/private/pagid/attachments/20120323/e24cfd00/attachment.html>
More information about the PAGID
mailing list